Phiroze Sethna

1.4k total citations
21 papers, 1.2k citations indexed

About

Phiroze Sethna is a scholar working on Infectious Diseases, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Phiroze Sethna has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Animal Science and Zoology. Recurrent topics in Phiroze Sethna's work include Viral gastroenteritis research and epidemiology (8 papers), Animal Virus Infections Studies (7 papers) and Virus-based gene therapy research (5 papers). Phiroze Sethna is often cited by papers focused on Viral gastroenteritis research and epidemiology (8 papers), Animal Virus Infections Studies (7 papers) and Virus-based gene therapy research (5 papers). Phiroze Sethna collaborates with scholars based in United States, United Kingdom and Italy. Phiroze Sethna's co-authors include David A. Brian, Martin Hofmann‐Apitius, Shan‐Ling Hung, Ruey-Yi Chang, Richard J. Harvey, Els Kievit, Theodore S. Lawrence, Eric M. Bershad, Enoch Ng and Alnawaz Rehemtulla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Journal of Virology.

In The Last Decade

Phiroze Sethna

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phiroze Sethna United States 17 637 542 278 272 199 21 1.2k
Andrea N. Loes United States 14 1.8k 2.8× 278 0.5× 757 2.7× 152 0.6× 143 0.7× 20 2.2k
Susanne Rauch Germany 17 696 1.1× 123 0.2× 693 2.5× 110 0.4× 185 0.9× 27 1.5k
Shoaleh Dehghan United States 16 417 0.7× 71 0.1× 245 0.9× 644 2.4× 288 1.4× 30 829
Wenjun Liu China 15 250 0.4× 228 0.4× 163 0.6× 93 0.3× 85 0.4× 40 624
Ivan L. Ângulo Brazil 18 231 0.4× 139 0.3× 221 0.8× 103 0.4× 101 0.5× 41 944
Fiona E. Fleming Australia 15 377 0.6× 156 0.3× 147 0.5× 114 0.4× 140 0.7× 17 607
Iwona Minor United States 12 424 0.7× 118 0.2× 447 1.6× 143 0.5× 455 2.3× 13 1.3k
Simon P. Tucker United States 20 298 0.5× 60 0.1× 313 1.1× 110 0.4× 414 2.1× 34 1.0k
P L Callahan United States 9 496 0.8× 53 0.1× 662 2.4× 129 0.5× 332 1.7× 9 1.3k
M. L. Celma Spain 14 283 0.4× 101 0.2× 388 1.4× 157 0.6× 750 3.8× 19 1.2k

Countries citing papers authored by Phiroze Sethna

Since Specialization
Citations

This map shows the geographic impact of Phiroze Sethna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phiroze Sethna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phiroze Sethna more than expected).

Fields of papers citing papers by Phiroze Sethna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phiroze Sethna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phiroze Sethna. The network helps show where Phiroze Sethna may publish in the future.

Co-authorship network of co-authors of Phiroze Sethna

This figure shows the co-authorship network connecting the top 25 collaborators of Phiroze Sethna. A scholar is included among the top collaborators of Phiroze Sethna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phiroze Sethna. Phiroze Sethna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Andrew, Scott A. Foster, Sara Morrow, et al.. (2023). Abstract 4914: Role of ClpP in the anti-cancer effects of imipridone ONC201 and ONC206. Cancer Research. 83(7_Supplement). 4914–4914. 1 indexed citations
2.
Foster, Scott A., Andrew Lee, Joshua E. Allen, et al.. (2022). EXTH-104. ROLE OF CLPP AND MITOCHONDRIAL METABOLISM IN THE ANTI-CANCER EFFECTS OF IMIPRIDONE ONC201 AND ONC206 IN GLIOBLASTOMA AND DIPG. Neuro-Oncology. 24(Supplement_7). vii234–vii234.
3.
Selleseth, Dean W., et al.. (2018). In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus. Antiviral Research. 158. 255–263. 21 indexed citations
4.
Bua, Gloria, Ilaria Conti, Elisabetta Manaresi, et al.. (2018). Antiviral activity of brincidofovir on parvovirus B19. Antiviral Research. 162. 22–29. 19 indexed citations
5.
6.
Bae, Andrew, Phiroze Sethna, Thomas M. Brundage, et al.. (2016). Role of Adenovirus Species and Type on Virologic Response to Brincidofovir. Biology of Blood and Marrow Transplantation. 22(3). S55–S55. 2 indexed citations
7.
McMullan, Laura K., Mike Flint, Julie Dyall, et al.. (2015). The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus. Antiviral Research. 125. 71–78. 36 indexed citations
8.
Miller, John F., Elizabeth M. Turner, Ronald G. Sherrill, et al.. (2009). Substituted tetrahydro-β-carbolines as potential agents for the treatment of human papillomavirus infection. Bioorganic & Medicinal Chemistry Letters. 20(1). 256–259. 30 indexed citations
9.
Gudmundsson, Kristjan S., Paul R. Sebahar, John G. Catalano, et al.. (2009). Substituted tetrahydrocarbazoles with potent activity against human papillomaviruses. Bioorganic & Medicinal Chemistry Letters. 19(13). 3489–3492. 42 indexed citations
10.
Gudmundsson, Kristjan S., Sharon Boggs, Paul R. Sebahar, et al.. (2009). Tetrahydrocarbazole amides with potent activity against human papillomaviruses. Bioorganic & Medicinal Chemistry Letters. 19(15). 4110–4114. 25 indexed citations
11.
Harvey, Richard J., Kevin Brown, Qin Zhang, et al.. (2009). GSK983: A novel compound with broad-spectrum antiviral activity. Antiviral Research. 82(1). 1–11. 52 indexed citations
12.
Krosky, Paula M., Moon‐Chang Baek, Wan Jin Jahng, et al.. (2003). The Human Cytomegalovirus UL44 Protein Is a Substrate for the UL97 Protein Kinase. Journal of Virology. 77(14). 7720–7727. 93 indexed citations
13.
Kievit, Els, Eric M. Bershad, Enoch Ng, et al.. (1999). Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts.. PubMed. 59(7). 1417–21. 149 indexed citations
14.
Sethna, Phiroze & David A. Brian. (1997). Coronavirus genomic and subgenomic minus-strand RNAs copartition in membrane-protected replication complexes. Journal of Virology. 71(10). 7744–7749. 34 indexed citations
15.
Brian, David A., Ruey-Yi Chang, Martin Hofmann‐Apitius, & Phiroze Sethna. (1994). Role of subgenomic minus-strand RNA in coronavirus replication. PubMed. 9. 173–180. 19 indexed citations
16.
Chang, Ruey-Yi, Martin Hofmann‐Apitius, Phiroze Sethna, & David A. Brian. (1994). A cis-acting function for the coronavirus leader in defective interfering RNA replication. Journal of Virology. 68(12). 8223–8231. 99 indexed citations
17.
18.
Sethna, Phiroze, Martin Hofmann‐Apitius, & David A. Brian. (1991). Minus-strand copies of replicating coronavirus mRNAs contain antileaders. Journal of Virology. 65(1). 320–325. 135 indexed citations
19.
Sethna, Phiroze, Shan‐Ling Hung, & David A. Brian. (1990). Coronavirus Subgenomic Replicons as a Mechanism for mRNA Amplification. Advances in experimental medicine and biology. 276. 335–340. 1 indexed citations
20.
Sethna, Phiroze, Shan‐Ling Hung, & David A. Brian. (1989). Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons.. Proceedings of the National Academy of Sciences. 86(14). 5626–5630. 206 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea N. Loes Breakdown of academic impact, for papers by Susanne Rauch Breakdown of academic impact, for papers by Shoaleh Dehghan Breakdown of academic impact, for papers by Wenjun Liu Breakdown of academic impact, for papers by Ivan L. Ângulo Breakdown of academic impact, for papers by Fiona E. Fleming Breakdown of academic impact, for papers by Iwona Minor Breakdown of academic impact, for papers by Simon P. Tucker Breakdown of academic impact, for papers by P L Callahan Breakdown of academic impact, for papers by M. L. Celma
Rankless by CCL
2026